Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Archives

You are currently viewing the 2011 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Patents Expiring in 2022

« Back to Dashboard
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Glaxosmithkline Llc
INNOPRAN XL
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE; ORAL021438Mar 12, 2003RXNo6,500,454<disabled>
Sanofi Aventis Us
OFORTA
fludarabine phosphate
TABLET; ORAL022273Dec 18, 2008RXYes7,148,207<disabled>YTREATMENT OF PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Alcon Pharms Ltd
PATADAY
olopatadine hydrochloride
SOLUTION/DROPS; OPHTHALMIC021545Dec 22, 2004RXYes7,402,609*PED<disabled>Y
Jazz
XYREM
sodium oxybate
SOLUTION; ORAL021196Jul 17, 2002RXYes7,895,059<disabled>METHOD OF TREATING A PATIENT WITH A PRESCRIPTION DRUG USING A COMPUTER DATABASE IN A COMPUTER SYSTEM FOR DISTRIBUTION
Mayne Pharma
DORYX
doxycycline hyclate
TABLET, DELAYED RELEASE; ORAL050795Jun 20, 2008RXYes6,958,161<disabled>YTO TREAT OR PREVENT INFECTIONS CAUSED BY SUSCEPTIBLE BACTERIA USING DELAYED-RELEASE TABLETS CONSISTING OF DOXYCYCLINE HYCLATE COATED PELLETS IN A TABLET
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc